EBR Systems
Founded Year
2003Stage
IPO | IPOTotal Raised
$150.21MDate of IPO
11/24/2021About EBR Systems
EBR Systems (ASX: EBR) offers cardiac rhythm management. It focuses on the treatment of cardiac rhythm disease by providing physiologically effective stimulation through wireless cardiac pacing. The company was founded in 2003 and is based in Sunnyvale, California.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
EBR Systems Patents
EBR Systems has filed 65 patents.
The 3 most popular patent topics include:
- Cardiac arrhythmia
- Implants (medicine)
- Energy conversion
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/20/2020 | 9/12/2023 | Wireless energy transfer, Cardiac arrhythmia, Cardiac electrophysiology, Energy conversion, Vacuum tubes | Grant |
Application Date | 5/20/2020 |
|---|---|
Grant Date | 9/12/2023 |
Title | |
Related Topics | Wireless energy transfer, Cardiac arrhythmia, Cardiac electrophysiology, Energy conversion, Vacuum tubes |
Status | Grant |
Latest EBR Systems News
Aug 21, 2023
5h agoPrivate Equityuk.sports.yahooViews: 6 EBR Systems, Inc.'s (ASX:EBR) top owners are private equity firms with 41% stake, while 28% is held by institutions Yahoo Eurosport UK Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN
EBR Systems Frequently Asked Questions (FAQ)
When was EBR Systems founded?
EBR Systems was founded in 2003.
Where is EBR Systems's headquarters?
EBR Systems's headquarters is located at 480 Oakmead Parkway, Sunnyvale.
What is EBR Systems's latest funding round?
EBR Systems's latest funding round is IPO.
How much did EBR Systems raise?
EBR Systems raised a total of $150.21M.
Who are the investors of EBR Systems?
Investors of EBR Systems include Paycheck Protection Program, Split Rock Partners, Emergent Medical Partners, Ascension Ventures, M.H. Carnegie & Co. and 8 more.
Who are EBR Systems's competitors?
Competitors of EBR Systems include NeoChord, Avalon Laboratories, SpineAlign Medical, Cardiophotonics, Orqis Medical and 11 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare EBR Systems to Competitors
Belmont Instrument developes devices in fluid management and cardiac assist.
EMCOOLS develops and globally commercializes easy to use, efficient cooling devices to benefit humans.
Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures. The Sniper balloon occlusion microcatheter aims to set a new standard for precise embolic delivery and target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. The company was founded in 2013 and is based in Sunnyvale, California.
Medical devices for the treatment of severe gastrointestinal disorders
C2C is a medical device company developing a portfolio of medical devices.
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
